Like their causative mutations, pathophysiology and natural history, the clinical presentation of inborn errors of immunity (IEI) varies widely. Nevertheless, some features, above all recurrent and/or ...

Diagnosis of ankylosing spondylitis/axial spondyloarthritis (AS/axSpA) at an early stage is not a simple task and is often missed or markedly delayed, especially in a primary care setting, unless the ...

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is a robust measure of neurodegenerative disease activity ...

VANCOUVER, British Columbia & SEATTLE--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced, in ...

Benitec Biopharma Inc., a biotechnology company based in Hayward, California, has announced the acceptance of a late-breaking oral abstract for its ongoing BB-301 Phase 1b/2a Clinical Treatment Study ...

Clinical psychology has long recognized that psychological distress and therapeutic change involve more than cognitive processes alone. Emotion regulation, ...